Propanc Biopharma (PPCB) Change in Cash (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Change in Cash of -$41500.0 for Q4 2025, down 873.53% year-over-year from $5365.0 in Q4 2024, and down 107.03% quarter-over-quarter from $590649.0 in Q3 2025.
Propanc Biopharma (PPCB) Change in Cash (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Change in Cash for 15 consecutive years, with -$41500.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Cash fell 873.53% year-over-year to -$41500.0; the TTM figure through Dec 2025 stood at $546604.0 (up 1058.67% YoY), while the FY2025 annual figure was -$8997.0, down 181.51% from the prior year.
- Change in Cash declined to -$41500.0 in Q4 2025 per PPCB's latest filing, from $590649.0 in the prior quarter.
- Across five years, Change in Cash topped out at $590649.0 in Q3 2025 and bottomed at -$129818.0 in Q2 2022.
- Historically, Change in Cash has averaged $26999.7 across 5 years, with a median of $5222.5 in 2022.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 965.48% — and 2025, when it soared 5098.3%.
- Propanc Biopharma's Change in Cash stood at $27799.0 in 2021, then tumbled by 81.73% to $5080.0 in 2022, then surged by 1180.02% to $65025.0 in 2023, then tumbled by 91.75% to $5365.0 in 2024, then sank by 873.53% to -$41500.0 in 2025.
- Business Quant data shows PPCB's Change in Cash at -$41500.0 in Q4 2025, $590649.0 in Q3 2025, and -$38672.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 225.59 Mn |
| 10 | Propanc Biopharma | 577,167.14 | 577,167.14 | - | -41,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41,500.00 |
| Sep 30, 2025 | 590,649.00 |
| Jun 30, 2025 | -38,672.00 |
| Mar 31, 2025 | 36,127.00 |
| Dec 31, 2024 | 5,365.00 |
| Sep 30, 2024 | -11,817.00 |
| Jun 30, 2024 | 14,863.00 |
| Mar 31, 2024 | -65,428.00 |
| Dec 31, 2023 | 65,025.00 |
| Sep 30, 2023 | -3,422.00 |
| Jun 30, 2023 | -83,194.00 |
| Mar 31, 2023 | 68,765.00 |
| Dec 31, 2022 | 5,080.00 |
| Sep 30, 2022 | 15,329.00 |
| Jun 30, 2022 | -129,818.00 |
| Mar 31, 2022 | 60,269.00 |
| Dec 31, 2021 | 27,799.00 |
| Sep 30, 2021 | 43,562.00 |
| Jun 30, 2021 | -12,184.00 |
| Mar 31, 2021 | -6,804.00 |